CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Net margin 2019–2025
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) net profit margin by fiscal year — reported net income divided by reported revenue.
-4.4%FY2025 · since FY2019: -78.7% → -4.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.4% | -1.3 pp |
| FY2024 | -3.1% | +13.8 pp |
| FY2023 | -16.9% | +14.0 pp |
| FY2022 | -31.0% | +9.0 pp |
| FY2021 | -39.9% | -19.7 pp |
| FY2020 | -20.3% | +58.4 pp |
| FY2019 | -78.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLOV financial trends
CLOV RevenueCLOV Net incomeCLOV Gross profitCLOV Gross marginCLOV Operating incomeCLOV Operating marginCLOV Operating cash flowCLOV Free cash flowCLOV Capital expendituresCLOV Return on equityCLOV Stock buybacksCLOV Dividends paidCLOV Total assetsCLOV Total liabilitiesCLOV Shareholders’ equityCLOV overview →